Samuel Frey is Co-Founder and Chief Product Officer at Aeon, a Swiss HealthTech company building Europe's most advanced AI-powered platform for early disease detection and preventive healthcare.

Samuel brings a decade of product leadership experience, most recently leading a successful turnaround at Vienna-based diagnostics scale-up Platomics, and prior to that held a product role at GoStudent.

Samuel co-founded Aeon with the conviction that healthcare must shift from reactive treatment to proactive, personalized prevention, leveraging AI to detect over 500 diseases before symptoms arise.

At Aeon, Samuel leads product strategy across the platform's three AI pillars: automated MRI imaging analysis, cross-validation of multi-modal diagnostics, and predictive personalized risk profiling.

Aeon has raised over $14M in total seed funding, achieved a zero percent false positive rate in clinical-grade follow-ups, and secured reimbursement agreements with Switzerland's largest health insurers, including KPT.